MycoBiomDB – Record Details (MyCo_2361)

Biomarker Record Details

Database ID: MyCo_2361
DB IDMyCo_2361
TitleEffects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice
Year2017
PMID28699245
Fungal Diseases involvedAspergillus fumigatus infection
Associated Medical ConditionNone
GenusAspergillus
Speciesfumigatus
OrganismAspergillus fumigatus
Ethical StatementAll animal studies were approved by the Ethics Review Committee for animal Experimentation of Nihon University. All Aspergillus fu- migatus studies were approved by the Microbial safety Management Committee of Nihon University School of Pharmacy (E-
Site of InfectionLungs
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceBronchoalveolar lavage fluid (BALF)
Host GroupAnimal
Host Common nameMice
Host Scientific nameMus musculus
Biomarker NameIL-
Biomarker Full NameInterleukin-17
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationJapan
CohortSpecific pathogen-
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsQuantikine® mouse ELISA kit (R&D systems, Inc., Minneapolis, MN, USA), OxiSelect® TBARS Assay Kit (Cell Biolabs Inc, San Diego, CA, USA), Platelia Aspergillus- EIA kits (Bio-­ Rad Laboratories, Redmond, WA, USA).
Assay DataNone
Validation Techniques usedGM-Platelia™ Aspergillus Ag ELISA, ELISA Based
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone